Read + Share
Amedeo Smart
Independent Medical Education
Liang Q, Zhu H, Huang BC, Lin TK, et al. Development of A10P3C, an isoform-selective inhibitor of EGLN2, for targeting breast cancer. Proc Natl Acad Sci U S A 2026;123:e2613915123.PMID: 42821343
Email
LinkedIn
Privacy Policy